Kyntra Bio, Inc. (KYNB) shareholders
Close on Nov 17, 2026Market cap $8.26MP/E 0.0Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Steven Boyd Joint filing with Armistice Capital, LLC (8.42%) | 8,500,000 | 8.42% | 13G (passive) amendment | Mar 31, 2025 |
| Armistice Capital, LLC Joint filing with Steven Boyd (9.88%) | 400,000 | 9.88% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of KYNB | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 400,000 | 9.88% | $3.02M | – | 0.04% |
| Vanguard Capital Management LLC | 159,950 | 3.95% | $1.21M | +3,343 | 0.00% |
| Acadian Asset Management LLC | 105,585 | 2.61% | $795.00K | – | 0.00% |
| BlackRock, Inc. | 84,330 | 2.08% | $636.69K | −1 | 0.00% |
| Geode Capital Management, LLC | 43,219 | 1.07% | $326.39K | −2,779 | 0.00% |
| HighTower Advisors, LLC | 39,746 | 0.98% | $300.08K | +2 | 0.00% |
| Two Sigma Investments, LP | 39,511 | 0.98% | $298.31K | −10,000 | 0.00% |
| Renaissance Technologies LLC | 27,081 | 0.67% | $204.46K | −400 | 0.00% |
| Vanguard Fiduciary Trust Co | 24,105 | 0.60% | $181.99K | +163 | 0.00% |
| Birchview Capital, LP | 22,566 | 0.56% | $170.37K | – | 0.08% |
| State Street Corp | 20,284 | 0.50% | $153.14K | – | 0.00% |
| Gsa Capital Partners Llp | 15,697 | 0.39% | $119.00K | New | 0.01% |
| UBS Group AG | 7,857 | 0.19% | $59.32K | −19,734 | 0.00% |
| Group One Trading, L.P. | 4,406 | 0.11% | $33.27K | −86 | 0.00% |
| Vanguard Global Advisers, LLC | 1,424 | 0.04% | $10.75K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 1,113 | 0.03% | $8.40K | +781 | 0.00% |
| Axiom Investment Management LLC | 704 | 0.02% | $5.32K | – | 0.00% |
| Morgan Stanley | 487 | 0.01% | $3.68K | −1 | 0.00% |
| Harbour Investments, Inc. | 200 | 0.00% | $1.51K | – | 0.00% |
| National Bank Of Canada /Fi/ | 193 | 0.00% | $1.45K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 27 | 1M | 24.7% | 1 / 6 | 8 / 5 | 0M | 0M |
| Q1 2026 | 32 | 1M | 25.6% | 8 / 5 | 8 / 8 | 0M | 0M |
| Q4 2025 | 34 | 1M | 28.7% | 6 / 8 | 10 / 4 | 0M | 0M |
| Q3 2025 | 32 | 1M | 28.0% | 4 / 9 | 8 / 1 | 0M | 0M |
| Q2 2025 | 29 | 1M | 25.8% | 29 / 0 | 0 / 0 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
10 funds held KYNB in Q2 2026, 79% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of KYNB | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 114,179 | 2.82% | $862.05K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 42,265 | 1.04% | $319.10K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 21,079 | 0.52% | $145.45K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 7,005 | 0.17% | $48.33K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 5,744 | 0.14% | $39.63K | 0.00% | May 31, 2026 |
| Vanguard Balanced Index Fund | 3,506 | 0.09% | $26.47K | 0.00% | Jun 30, 2026 |
| Vanguard Capital Opportunity Fund | 2,716 | 0.07% | $20.51K | 0.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 1,991 | 0.05% | $13.74K | 0.00% | May 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 185 | 0.00% | $1.40K | 0.00% | Jun 30, 2026 |
| Knights of Columbus U.S. ALL CAP INDEX FUND | 22 | 0.00% | $147 | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Thane Wettig | CEO, Director | 29,336 | 0.72% | Nov 17, 2026 |
| David DeLucia | Chief Financial Officer | 4,355 | 0.11% | Sep 9, 2026 |
| Christine Chung | SVP, CHINA OPERATIONS | 294,544 | 7.27% | Mar 7, 2025 |
| Juan Graham | CHIEF FINANCIAL OFFICER | 164,863 | 4.07% | Dec 9, 2024 |
| Andrew E. Singer | Director | – | – | Oct 6, 2026 |
| Maykin Ho | Director | 37,726 | 0.93% | Jun 17, 2026 |
| Michael Kauffman | Director | – | – | Jun 17, 2026 |
| James A. Schoeneck | Director | 68,432 | 1.69% | Jun 17, 2026 |
| Jeffrey L. Edwards | Director | 38,601 | 0.95% | Jun 17, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Thane Wettig CEO, Director | Nov 15, 2026 | Award | +2,500 | $2.92 | $7.31K | 29,296 |
| Thane Wettig CEO, Director | Sep 6, 2026 | Tax withholding | −209 | $8.55 | $1.79K | 26,796 |
| David DeLucia Chief Financial Officer | Sep 6, 2026 | Tax withholding | −22 | $8.55 | $188 | 4,355 |
| David DeLucia Chief Financial Officer | Jun 6, 2026 | Tax withholding | −52 | $6.71 | $349 | 4,377 |
| Thane Wettig CEO, Director | Jun 6, 2026 | Tax withholding | −198 | $6.71 | $1.33K | 27,005 |
| Thane Wettig CEO, Director | May 14, 2026 | Buy | +2,800 | $7.09 | $19.85K | 27,203 |
| Thane Wettig CEO, Director | May 14, 2026 | Buy | −2,800 | $7.09 | $19.85K | 27,203 |
| Thane Wettig CEO, Director | Mar 6, 2026 | Tax withholding | −277 | $6.84 | $1.89K | 24,403 |
| David DeLucia Chief Financial Officer | Mar 6, 2026 | Tax withholding | −60 | $6.84 | $410 | 4,429 |
| David DeLucia Chief Financial Officer | Dec 6, 2025 | Tax withholding | −52 | $8.42 | $438 | 4,489 |
| Thane Wettig CEO, Director | Dec 6, 2025 | Tax withholding | −259 | $8.42 | $2.18K | 24,680 |
| Thane Wettig CEO, Director | Nov 17, 2025 | Buy | +2,700 | $9.10 | $24.57K | 24,939 |
| Thane Wettig CEO, Director | Nov 13, 2025 | Buy | +1,000 | $9.18 | $9.18K | 22,239 |
| David DeLucia Chief Financial Officer | Sep 6, 2025 | Tax withholding | −53 | $12.10 | $641 | 4,541 |
| Thane Wettig CEO, Director | Sep 6, 2025 | Tax withholding | −248 | $12.10 | $3.00K | 21,239 |
| James A. Schoeneck Director | Jun 30, 2025 | Buy | +23,567 | $5.07 | $119.48K | 39,666 |
| David DeLucia Chief Financial Officer | Jun 6, 2025 | Tax withholding | −51 | $7.83 | $399 | 4,594 |
| Thane Wettig CEO, Director | Jun 6, 2025 | Tax withholding | −246 | $7.83 | $1.93K | 21,487 |
| Thane Wettig CEO, Director | Mar 24, 2025 | Buy | +145,000 | $0.35 | $50.75K | 543,329 |
| James A. Schoeneck Director | Mar 21, 2025 | Buy | +50,000 | $0.34 | $17.00K | 373,722 |
| James A. Schoeneck Director | Mar 20, 2025 | Buy | +250,000 | $0.35 | $87.50K | 323,722 |
| David DeLucia Chief Financial Officer | Mar 6, 2025 | Tax withholding | −2,325 | $0.39 | $907 | 116,137 |
| Christine Chung SVP, CHINA OPERATIONS | Mar 6, 2025 | Tax withholding | −7,008 | $0.39 | $2.73K | 294,544 |
| Christine Chung SVP, CHINA OPERATIONS | Mar 6, 2025 | Tax withholding | −422 | $0.39 | $165 | 294,903 |
| Christine Chung SVP, CHINA OPERATIONS | Mar 6, 2025 | Award | +781 | – | – | 295,325 |
| Thane Wettig CEO, Director | Mar 6, 2025 | Tax withholding | −22,038 | $0.39 | $8.59K | 397,915 |
| Thane Wettig CEO, Director | Mar 6, 2025 | Tax withholding | −367 | $0.39 | $143 | 398,329 |
| Thane Wettig CEO, Director | Mar 6, 2025 | Award | +781 | – | – | 398,696 |
| Juan Graham CHIEF FINANCIAL OFFICER | Dec 7, 2024 | Tax withholding | −1,066 | $0.34 | $362 | 164,863 |
| Juan Graham CHIEF FINANCIAL OFFICER | Dec 6, 2024 | Tax withholding | −1,446 | $0.34 | $492 | 165,929 |
| Christine Chung SVP, CHINA OPERATIONS | Dec 6, 2024 | Tax withholding | −2,792 | $0.34 | $949 | 301,552 |
| Thane Wettig CEO, Director | Dec 6, 2024 | Tax withholding | −2,363 | $0.34 | $803 | 419,953 |
| Juan Graham CHIEF FINANCIAL OFFICER | Sep 7, 2024 | Tax withholding | −1,065 | $0.39 | $415 | 167,375 |
| Christine Chung SVP, CHINA OPERATIONS | Sep 6, 2024 | Tax withholding | −17,395 | $0.39 | $6.78K | 304,344 |
| Juan Graham CHIEF FINANCIAL OFFICER | Sep 6, 2024 | Tax withholding | −16,050 | $0.39 | $6.26K | 168,440 |
| Thane Wettig CEO, Director | Sep 6, 2024 | Tax withholding | −2,363 | $0.39 | $922 | 422,316 |
| Thane Wettig CEO, Director | Aug 1, 2024 | Tax withholding | −20,840 | $0.47 | $9.79K | 424,679 |
| Thane Wettig CEO, Director | Jun 22, 2024 | Tax withholding | −782 | $1.13 | $884 | 445,519 |
| Deyaa Adib Chief Medical Officer | Jun 12, 2024 | Buy | +22,123 | $1.17 | $25.88K | 82,123 |
| Juan Graham CHIEF FINANCIAL OFFICER | Jun 7, 2024 | Tax withholding | −1,182 | $1.10 | $1.30K | 184,490 |
| Juan Graham CHIEF FINANCIAL OFFICER | Jun 6, 2024 | Tax withholding | −17,797 | $1.19 | $21.18K | 185,672 |
| Christine Chung SVP, CHINA OPERATIONS | Jun 6, 2024 | Tax withholding | −19,289 | $1.19 | $22.95K | 321,739 |
| Thane Wettig CEO, Director | Jun 6, 2024 | Tax withholding | −2,255 | $1.19 | $2.68K | 446,301 |
| Thane Wettig CEO, Director | May 1, 2024 | Tax withholding | −20,840 | $1.17 | $24.38K | 448,556 |
| Thane Wettig CEO, Director | Mar 22, 2024 | Tax withholding | −782 | $2.58 | $2.02K | 469,396 |
| Thane Wettig CEO | Mar 7, 2024 | Buy | +50,000 | $1.91 | $95.50K | 470,178 |
| Juan Graham CHIEF FINANCIAL OFFICER | Mar 7, 2024 | Tax withholding | −1,181 | $1.79 | $2.11K | 203,469 |
| Thane Wettig CEO | Mar 6, 2024 | Tax withholding | −4,209 | $1.87 | $7.87K | 419,723 |
| Thane Wettig CEO | Mar 6, 2024 | Award | +781 | – | – | 420,504 |
| Thane Wettig CEO | Mar 6, 2024 | Tax withholding | −326 | $1.87 | $610 | 420,178 |
| Juan Graham CHIEF FINANCIAL OFFICER | Mar 6, 2024 | Tax withholding | −20,327 | $1.87 | $38.01K | 204,291 |
| Juan Graham CHIEF FINANCIAL OFFICER | Mar 6, 2024 | Award | +781 | – | – | 205,072 |
| Juan Graham CHIEF FINANCIAL OFFICER | Mar 6, 2024 | Tax withholding | −422 | $1.87 | $789 | 204,650 |
| Christine Chung SVP, CHINA OPERATIONS | Mar 6, 2024 | Tax withholding | −422 | $1.87 | $789 | 341,028 |
| Christine Chung SVP, CHINA OPERATIONS | Mar 6, 2024 | Tax withholding | −23,168 | $1.87 | $43.32K | 340,669 |
| Christine Chung SVP, CHINA OPERATIONS | Mar 6, 2024 | Award | +781 | – | – | 341,450 |
| Christine Chung SVP, CHINA OPERATIONS | Feb 21, 2024 | Award | +29,000 | – | – | 363,837 |
| Thane Wettig CEO | Feb 21, 2024 | Award | +166,000 | – | – | 423,932 |
| Juan Graham CHIEF FINANCIAL OFFICER | Feb 21, 2024 | Award | +52,000 | – | – | 224,618 |
| Thane Wettig CEO | Feb 1, 2024 | Tax withholding | −23,490 | $2.37 | $55.67K | 257,932 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 10 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Kyntra Bio's stock actually held short. Settlement fails (shares not delivered on time) peaked at 800 shares on Aug 24, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Jeffrey Henderson Director | Sep 1, 2023 | 2,000 | $2.12K | Sep 1, 2023 | Acquired as compensation -- Restricted Stock Units |
| Jeffrey Henderson Director | Aug 4, 2023 | 2,000 | $3.82K | Aug 4, 2023 | Acquired as compensation -- Restricted Stock Units |
| Jeffrey Henderson Director | Jul 11, 2023 | 2,000 | $5.46K | Jul 11, 2023 | Acquired as compensation -- Restricted Stock Units |
| Thane Wettig Officer | Jun 23, 2023 | 791 | $13.07K | Jun 23, 2023 | RESTRICTED STOCK |
| Christine Chung Officer | Jun 13, 2023 | 62,500 | $1.10M | Jun 13, 2023 | Compensation-- Restricted Stock Units |
| Benjamin Cravatt Director | Jun 9, 2023 | 3,944 | $67.72K | Jun 9, 2023 | Restricted Stock |
| Suzanne Blaug Director | Jun 9, 2023 | 8,520 | $146.55K | Jun 9, 2023 | Restricted Stock |
| Jeffrey L. Edwards Director | Jun 9, 2023 | 7,889 | $135.61K | Jun 9, 2023 | Restricted Stock |
| Aoife Brennan Director | Jun 9, 2023 | 4,733 | $81.36K | Jun 9, 2023 | Restricted Stock |
| Jeffrey Henderson Director | Jun 8, 2023 | 7,000 | $124.46K | Jun 8, 2023 | Acquired as compensation -- Restricted Stock Units |
| Juan Graham Officer | Jun 8, 2023 | 1,050 | $17.80K | Jun 8, 2023 | RESTRICTED STOCK |
| May-Kin Ho Director | Jun 8, 2023 | 8,520 | $151.49K | Jun 8, 2023 | Acquired as compensation -- Restricted Stock Units |
| Thane Wettig Officer | Jun 7, 2023 | 1,758 | $29.95K | Jun 7, 2023 | RESTRICTED STOCK |
| Juan Graham Officer | Jun 7, 2023 | 1,406 | $23.96K | Jun 7, 2023 | RESTRICTED STOCK |
| James A. Schoeneck Director | Jun 7, 2023 | 7,100 | $127.99K | Jun 7, 2023 | RSU Vest |
See a number that looks wrong?